Vaccine sales dragged on 2024 results as shingles, flu and RSV shots fell back versus the prior year, but GSKs other key therapeutic areas, including HIV, respiratory/immunology, oncology and respiratory, grew
The use of their NOX-inhibitory properties in vivo may thus be problematic (Cipriano et al., 2023)
GLP-1 users are significantly cutting back on dining in and ordering takeout, according to a report published this week by Bloomberg Intelligence
PCAC will discuss inclusion on the 503A Bulks List
B12 helps to regulate homocysteine metabolism, which can affect inflammation pathways
[39] A 2025 study in which some Parkinson's patients received exenatide found no evidence that it slowed disease progression or provided any benefit after 96 weeks